CN Stock MarketDetailed Quotes

600750 Jiangzhong Pharmaceutical

Watchlist
  • 21.02
  • -0.36-1.68%
Market Closed Dec 13 15:00 CST
13.22BMarket Cap17.62P/E (TTM)

Jiangzhong Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-8.19%2.97B
-8.02%2.17B
-8.74%1.23B
13.00%4.39B
12.61%3.24B
24.26%2.36B
44.50%1.34B
35.19%3.89B
48.33%2.87B
50.12%1.9B
Operating revenue
-8.19%2.97B
-8.02%2.17B
-8.74%1.23B
13.00%4.39B
12.61%3.24B
24.26%2.36B
44.50%1.34B
35.19%3.89B
48.33%2.87B
50.12%1.9B
Other operating revenue
----
-19.09%17.62M
----
-33.80%26.21M
----
-49.24%21.77M
----
121.34%39.58M
----
1,408.43%42.89M
Total operating cost
-13.07%2.22B
-13.43%1.6B
-15.24%899.42M
8.30%3.5B
10.43%2.55B
26.36%1.84B
47.03%1.06B
38.08%3.23B
59.61%2.31B
56.42%1.46B
Operating cost
-11.23%960.83M
-13.77%672.58M
-13.08%383.29M
10.02%1.52B
12.57%1.08B
22.83%779.95M
49.36%440.96M
35.07%1.38B
46.96%961.56M
48.85%634.98M
Operating tax surcharges
-2.17%45.31M
1.66%32.37M
1.58%17.71M
4.84%62.65M
1.15%46.31M
0.07%31.85M
15.32%17.43M
13.93%59.75M
15.66%45.78M
21.50%31.82M
Operating expense
-15.48%1.06B
-15.17%780.76M
-16.14%451.23M
7.99%1.63B
11.07%1.25B
34.88%920.44M
52.34%538.07M
46.17%1.51B
78.13%1.12B
71.78%682.39M
Administration expense
-5.74%136.35M
-6.80%86.54M
-20.98%39.86M
2.34%210.62M
14.50%144.65M
17.42%92.86M
32.51%50.45M
24.70%205.8M
30.95%126.33M
19.66%79.08M
Financial expense
-37.09%-59.55M
-53.50%-40.82M
-71.23%-21.29M
-116.74%-59.8M
-97.51%-43.44M
-108.35%-26.59M
-57.37%-12.43M
-23.07%-27.59M
3.43%-21.99M
19.36%-12.76M
-Interest expense (Financial expense)
-93.49%251.88K
-93.24%231.23K
-98.96%16.8K
59.38%6.98M
140.90%3.87M
149.32%3.42M
2,824.40%1.62M
26.51%4.38M
10,874.70%1.61M
8,188.57%1.37M
-Interest Income (Financial expense)
-25.23%-60.13M
-36.59%-41.27M
-51.29%-21.41M
-107.29%-67.64M
-99.13%-48.01M
-110.81%-30.21M
-75.83%-14.15M
-24.08%-32.63M
-4.94%-24.11M
10.34%-14.33M
Research and development
9.91%77.86M
42.20%65.05M
7.41%28.62M
33.37%133.33M
-2.80%70.84M
3.88%45.75M
-4.76%26.64M
13.83%99.97M
52.60%72.88M
34.29%44.04M
Credit Impairment Loss
217.78%23.03M
360.28%23.86M
658.32%11.4M
92.70%-1.03M
10.71%7.25M
18.73%5.18M
-56.14%1.5M
-74.70%-14.05M
616.53%6.55M
648.54%4.37M
Asset Impairment Loss
-162,465.75%-8.04M
-153,703.37%-7.61M
---8.22M
-7,770.23%-8.85M
-99.80%4.95K
-99.88%4.95K
----
91.85%-112.5K
2,002.27%2.54M
4,248.57%4.28M
Other net revenue
16.20%50.84M
-6.72%40.14M
-60.14%7.23M
-97.88%1.98M
-41.52%43.76M
-16.19%43.03M
-10.58%18.14M
2.08%93.11M
13.93%74.82M
36.98%51.35M
Fair value change income
-85.20%844.29K
-95.09%844.28K
-91.35%620.29K
-164.99%-37.11M
-85.18%5.7M
-23.04%17.21M
-22.10%7.17M
6.50%57.1M
25.15%38.49M
29.49%22.36M
Invest income
-373.71%-2.61M
-807.10%-1.44M
55.27%-156.92K
-167.23%-2.94M
-81.43%953.69K
-103.82%-158.59K
-129.50%-350.86K
284.88%4.37M
2,688.24%5.14M
561.45%4.15M
-Including: Investment income associates
-242.61%-1.36M
-198.94%-474.1K
41.35%-205.78K
-257.74%-2.94M
72.57%953.69K
-134.83%-158.59K
-129.23%-350.86K
72.82%-821.16K
216.85%552.65K
148.86%455.35K
Asset deal income
-5,557.23%-292.78K
1,334.57%70.26K
7,296.53%43.74K
1,008.80%1.22M
-89.21%5.36K
-90.67%4.9K
117.77%591.41
-114.87%-134.14K
-94.50%49.7K
-94.20%52.5K
Other revenue
27.04%37.91M
17.41%24.41M
-63.92%3.54M
10.34%50.68M
35.21%29.84M
28.87%20.79M
258.01%9.82M
-5.25%45.93M
-33.22%22.07M
-18.25%16.13M
Operating profit
10.30%806.85M
9.88%616.18M
11.03%335.22M
19.47%894.12M
14.17%731.52M
13.82%560.78M
31.66%301.91M
19.56%748.41M
14.99%640.71M
32.93%492.68M
Add:Non operating Income
-23.73%6.03M
-10.96%4.82M
-76.30%1.2M
23.93%9.07M
226.25%7.91M
306.72%5.42M
645.58%5.05M
237.74%7.32M
65.20%2.42M
46.92%1.33M
Less:Non operating expense
291.82%5.32M
29.05%1.16M
-28.85%356.7K
147.59%6.05M
29.68%1.36M
19.53%902.48K
289.21%501.3K
-51.25%2.44M
-56.43%1.05M
215.18%755.02K
Total profit
9.42%807.56M
9.65%619.84M
9.66%336.06M
19.10%897.13M
14.95%738.07M
14.61%565.3M
33.32%306.46M
20.88%753.28M
15.43%642.08M
32.85%493.25M
Less:Income tax cost
11.87%123.67M
7.99%95.42M
10.25%51.51M
22.06%130.47M
6.60%110.55M
9.92%88.36M
28.83%46.72M
15.94%106.89M
15.44%103.7M
46.01%80.39M
Net profit
8.98%683.89M
9.96%524.42M
9.55%284.55M
18.61%766.66M
16.56%627.52M
15.52%476.93M
34.17%259.74M
21.74%646.39M
15.42%538.38M
30.56%412.86M
Net profit from continuing operation
8.98%683.89M
9.96%524.42M
9.55%284.55M
18.61%766.66M
16.56%627.52M
15.52%476.93M
34.17%259.74M
21.74%646.39M
15.42%538.38M
30.56%412.86M
Less:Minority Profit
40.80%49.55M
31.44%35.67M
3.38%17.77M
21.22%58.37M
5.23%35.19M
31.92%27.13M
73.60%17.18M
90.61%48.15M
128.98%33.44M
112.98%20.57M
Net profit of parent company owners
7.09%634.34M
8.66%488.75M
9.99%266.78M
18.40%708.29M
17.31%592.33M
14.66%449.8M
32.04%242.56M
18.30%598.24M
11.75%504.94M
27.96%392.29M
Earning per share
Basic earning per share
7.45%1.01
8.33%0.78
10.26%0.43
17.89%1.12
17.50%0.94
16.13%0.72
34.48%0.39
18.75%0.95
11.11%0.8
26.53%0.62
Diluted earning per share
7.45%1.01
8.33%0.78
10.26%0.43
17.89%1.12
17.50%0.94
16.13%0.72
34.48%0.39
18.75%0.95
11.11%0.8
26.53%0.62
Other composite income
Total composite income
8.98%683.89M
9.96%524.42M
9.55%284.55M
18.61%766.66M
16.56%627.52M
15.52%476.93M
34.17%259.74M
21.74%646.39M
15.42%538.38M
30.56%412.86M
Total composite income of parent company owners
7.09%634.34M
8.66%488.75M
9.99%266.78M
18.40%708.29M
17.31%592.33M
14.66%449.8M
32.04%242.56M
18.30%598.24M
11.75%504.94M
27.96%392.29M
Total composite income of minority owners
40.80%49.55M
31.44%35.67M
3.38%17.77M
21.22%58.37M
5.23%35.19M
31.92%27.13M
73.60%17.18M
90.61%48.15M
128.98%33.44M
112.98%20.57M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -8.19%2.97B-8.02%2.17B-8.74%1.23B13.00%4.39B12.61%3.24B24.26%2.36B44.50%1.34B35.19%3.89B48.33%2.87B50.12%1.9B
Operating revenue -8.19%2.97B-8.02%2.17B-8.74%1.23B13.00%4.39B12.61%3.24B24.26%2.36B44.50%1.34B35.19%3.89B48.33%2.87B50.12%1.9B
Other operating revenue -----19.09%17.62M-----33.80%26.21M-----49.24%21.77M----121.34%39.58M----1,408.43%42.89M
Total operating cost -13.07%2.22B-13.43%1.6B-15.24%899.42M8.30%3.5B10.43%2.55B26.36%1.84B47.03%1.06B38.08%3.23B59.61%2.31B56.42%1.46B
Operating cost -11.23%960.83M-13.77%672.58M-13.08%383.29M10.02%1.52B12.57%1.08B22.83%779.95M49.36%440.96M35.07%1.38B46.96%961.56M48.85%634.98M
Operating tax surcharges -2.17%45.31M1.66%32.37M1.58%17.71M4.84%62.65M1.15%46.31M0.07%31.85M15.32%17.43M13.93%59.75M15.66%45.78M21.50%31.82M
Operating expense -15.48%1.06B-15.17%780.76M-16.14%451.23M7.99%1.63B11.07%1.25B34.88%920.44M52.34%538.07M46.17%1.51B78.13%1.12B71.78%682.39M
Administration expense -5.74%136.35M-6.80%86.54M-20.98%39.86M2.34%210.62M14.50%144.65M17.42%92.86M32.51%50.45M24.70%205.8M30.95%126.33M19.66%79.08M
Financial expense -37.09%-59.55M-53.50%-40.82M-71.23%-21.29M-116.74%-59.8M-97.51%-43.44M-108.35%-26.59M-57.37%-12.43M-23.07%-27.59M3.43%-21.99M19.36%-12.76M
-Interest expense (Financial expense) -93.49%251.88K-93.24%231.23K-98.96%16.8K59.38%6.98M140.90%3.87M149.32%3.42M2,824.40%1.62M26.51%4.38M10,874.70%1.61M8,188.57%1.37M
-Interest Income (Financial expense) -25.23%-60.13M-36.59%-41.27M-51.29%-21.41M-107.29%-67.64M-99.13%-48.01M-110.81%-30.21M-75.83%-14.15M-24.08%-32.63M-4.94%-24.11M10.34%-14.33M
Research and development 9.91%77.86M42.20%65.05M7.41%28.62M33.37%133.33M-2.80%70.84M3.88%45.75M-4.76%26.64M13.83%99.97M52.60%72.88M34.29%44.04M
Credit Impairment Loss 217.78%23.03M360.28%23.86M658.32%11.4M92.70%-1.03M10.71%7.25M18.73%5.18M-56.14%1.5M-74.70%-14.05M616.53%6.55M648.54%4.37M
Asset Impairment Loss -162,465.75%-8.04M-153,703.37%-7.61M---8.22M-7,770.23%-8.85M-99.80%4.95K-99.88%4.95K----91.85%-112.5K2,002.27%2.54M4,248.57%4.28M
Other net revenue 16.20%50.84M-6.72%40.14M-60.14%7.23M-97.88%1.98M-41.52%43.76M-16.19%43.03M-10.58%18.14M2.08%93.11M13.93%74.82M36.98%51.35M
Fair value change income -85.20%844.29K-95.09%844.28K-91.35%620.29K-164.99%-37.11M-85.18%5.7M-23.04%17.21M-22.10%7.17M6.50%57.1M25.15%38.49M29.49%22.36M
Invest income -373.71%-2.61M-807.10%-1.44M55.27%-156.92K-167.23%-2.94M-81.43%953.69K-103.82%-158.59K-129.50%-350.86K284.88%4.37M2,688.24%5.14M561.45%4.15M
-Including: Investment income associates -242.61%-1.36M-198.94%-474.1K41.35%-205.78K-257.74%-2.94M72.57%953.69K-134.83%-158.59K-129.23%-350.86K72.82%-821.16K216.85%552.65K148.86%455.35K
Asset deal income -5,557.23%-292.78K1,334.57%70.26K7,296.53%43.74K1,008.80%1.22M-89.21%5.36K-90.67%4.9K117.77%591.41-114.87%-134.14K-94.50%49.7K-94.20%52.5K
Other revenue 27.04%37.91M17.41%24.41M-63.92%3.54M10.34%50.68M35.21%29.84M28.87%20.79M258.01%9.82M-5.25%45.93M-33.22%22.07M-18.25%16.13M
Operating profit 10.30%806.85M9.88%616.18M11.03%335.22M19.47%894.12M14.17%731.52M13.82%560.78M31.66%301.91M19.56%748.41M14.99%640.71M32.93%492.68M
Add:Non operating Income -23.73%6.03M-10.96%4.82M-76.30%1.2M23.93%9.07M226.25%7.91M306.72%5.42M645.58%5.05M237.74%7.32M65.20%2.42M46.92%1.33M
Less:Non operating expense 291.82%5.32M29.05%1.16M-28.85%356.7K147.59%6.05M29.68%1.36M19.53%902.48K289.21%501.3K-51.25%2.44M-56.43%1.05M215.18%755.02K
Total profit 9.42%807.56M9.65%619.84M9.66%336.06M19.10%897.13M14.95%738.07M14.61%565.3M33.32%306.46M20.88%753.28M15.43%642.08M32.85%493.25M
Less:Income tax cost 11.87%123.67M7.99%95.42M10.25%51.51M22.06%130.47M6.60%110.55M9.92%88.36M28.83%46.72M15.94%106.89M15.44%103.7M46.01%80.39M
Net profit 8.98%683.89M9.96%524.42M9.55%284.55M18.61%766.66M16.56%627.52M15.52%476.93M34.17%259.74M21.74%646.39M15.42%538.38M30.56%412.86M
Net profit from continuing operation 8.98%683.89M9.96%524.42M9.55%284.55M18.61%766.66M16.56%627.52M15.52%476.93M34.17%259.74M21.74%646.39M15.42%538.38M30.56%412.86M
Less:Minority Profit 40.80%49.55M31.44%35.67M3.38%17.77M21.22%58.37M5.23%35.19M31.92%27.13M73.60%17.18M90.61%48.15M128.98%33.44M112.98%20.57M
Net profit of parent company owners 7.09%634.34M8.66%488.75M9.99%266.78M18.40%708.29M17.31%592.33M14.66%449.8M32.04%242.56M18.30%598.24M11.75%504.94M27.96%392.29M
Earning per share
Basic earning per share 7.45%1.018.33%0.7810.26%0.4317.89%1.1217.50%0.9416.13%0.7234.48%0.3918.75%0.9511.11%0.826.53%0.62
Diluted earning per share 7.45%1.018.33%0.7810.26%0.4317.89%1.1217.50%0.9416.13%0.7234.48%0.3918.75%0.9511.11%0.826.53%0.62
Other composite income
Total composite income 8.98%683.89M9.96%524.42M9.55%284.55M18.61%766.66M16.56%627.52M15.52%476.93M34.17%259.74M21.74%646.39M15.42%538.38M30.56%412.86M
Total composite income of parent company owners 7.09%634.34M8.66%488.75M9.99%266.78M18.40%708.29M17.31%592.33M14.66%449.8M32.04%242.56M18.30%598.24M11.75%504.94M27.96%392.29M
Total composite income of minority owners 40.80%49.55M31.44%35.67M3.38%17.77M21.22%58.37M5.23%35.19M31.92%27.13M73.60%17.18M90.61%48.15M128.98%33.44M112.98%20.57M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------KPMG Huazhen Certified Public Accountants (Special General Partnership)------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme State-owned Enterprise Reform
State-owned Enterprise Reform
Intraday-1.75%
ShangHai Stock Connect
ShangHai Stock Connect
Intraday-1.84%
Pharmaceutical E-commerce
Pharmaceutical E-commerce
Intraday-1.88%